Zydus Cadila gets USFDA nod for thyroid drug

Zydus Cadila has received final approval from the US Food and Drug
Administration (USFDA) to market Liothyronine Sodium tablets USP, 5
mcg, 25 mcg, and 50 mcg, Cadila Healthcare said in a regulatory
filing.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-cadila-gets-usfda-nod-for-thyroid-drug/articleshow/80419090.cms

Comments

Popular posts from this blog

Biotecnika Times Newsletter 25.10.2021 Tata Innovation Fellowship 2021, NCCS PhD Admission

TIGS-CI Biological Sciences Research Assistant Recruitment, Apply Online